209 related articles for article (PubMed ID: 11545614)
1. VSV-G envelope glycoprotein forms complexes with plasmid DNA and MLV retrovirus-like particles in cell-free conditions and enhances DNA transfection.
Okimoto T; Friedmann T; Miyanohara A
Mol Ther; 2001 Sep; 4(3):232-8. PubMed ID: 11545614
[TBL] [Abstract][Full Text] [Related]
2. Preparation of vesicular stomatitis virus-G (VSV-G) conjugate and its use in gene transfer.
Miyanohara A
Cold Spring Harb Protoc; 2012 Apr; 2012(4):453-6. PubMed ID: 22474657
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent transduction of vesicular stomatitis virus G protein-pseudotyped retrovirus vector into human solid tumor cell lines and murine fibroblasts.
Arai T; Takada M; Ui M; Iba H
Virology; 1999 Jul; 260(1):109-15. PubMed ID: 10405362
[TBL] [Abstract][Full Text] [Related]
4. Preparation and quantification of pseudotyped retroviral vector.
Yu H; Kwon YJ
Methods Mol Biol; 2008; 433():1-16. PubMed ID: 18679614
[TBL] [Abstract][Full Text] [Related]
5. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope.
Haglund K; Forman J; Kräusslich HG; Rose JK
Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333
[TBL] [Abstract][Full Text] [Related]
6. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
[TBL] [Abstract][Full Text] [Related]
7. Cell surface heparan sulfate is a receptor for attachment of envelope protein-free retrovirus-like particles and VSV-G pseudotyped MLV-derived retrovirus vectors to target cells.
Guibinga GH; Miyanohara A; Esko JD; Friedmann T
Mol Ther; 2002 May; 5(5 Pt 1):538-46. PubMed ID: 11991744
[TBL] [Abstract][Full Text] [Related]
8. In vitro cell-free conversion of noninfectious Moloney retrovirus particles to an infectious form by the addition of the vesicular stomatitis virus surrogate envelope G protein.
Abe A; Chen ST; Miyanohara A; Friedmann T
J Virol; 1998 Aug; 72(8):6356-61. PubMed ID: 9658075
[TBL] [Abstract][Full Text] [Related]
9. Vesicular stomatitis virus glycoprotein: a transducing coat for SFV-based RNA vectors.
Dorange F; Piver E; Bru T; Collin C; Roingeard P; Pagès JC
J Gene Med; 2004 Sep; 6(9):1014-22. PubMed ID: 15352074
[TBL] [Abstract][Full Text] [Related]
10. Antibody-dependent gene transduction using gammaretroviral and lentiviral vectors pseudotyped with chimeric vesicular stomatitis virus glycoprotein.
Kameyama Y; Kawabe Y; Ito A; Kamihira M
J Virol Methods; 2008 Oct; 153(1):49-54. PubMed ID: 18606189
[TBL] [Abstract][Full Text] [Related]
11. Development of inducible EIAV-based lentiviral vector packaging and producer cell lines.
Stewart HJ; Leroux-Carlucci MA; Sion CJ; Mitrophanous KA; Radcliffe PA
Gene Ther; 2009 Jun; 16(6):805-14. PubMed ID: 19262613
[TBL] [Abstract][Full Text] [Related]
12. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.
Sandrin V; Muriaux D; Darlix JL; Cosset FL
J Virol; 2004 Jul; 78(13):7153-64. PubMed ID: 15194792
[TBL] [Abstract][Full Text] [Related]
13. Retro-transduction by virus pseudotyped with glycoprotein of vesicular stomatitis virus.
Ohishi M; Shioda T; Sakuragi J
Virology; 2007 May; 362(1):131-8. PubMed ID: 17258261
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the gene delivery properties of baculoviral-based virosomal vectors.
Guibinga GH; Song S; Loring J; Friedmann T
J Virol Methods; 2008 Mar; 148(1-2):277-82. PubMed ID: 18207578
[TBL] [Abstract][Full Text] [Related]
15. Factors that influence VSV-G pseudotyping and transduction efficiency of lentiviral vectors-in vitro and in vivo implications.
Farley DC; Iqball S; Smith JC; Miskin JE; Kingsman SM; Mitrophanous KA
J Gene Med; 2007 May; 9(5):345-56. PubMed ID: 17366519
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus.
Kuate S; Stahl-Hennig C; Stoiber H; Nchinda G; Floto A; Franz M; Sauermann U; Bredl S; Deml L; Ignatius R; Norley S; Racz P; Tenner-Racz K; Steinman RM; Wagner R; Uberla K
Virology; 2006 Jul; 351(1):133-44. PubMed ID: 16616946
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an alternative packaging system derived from the cat RD114 retrovirus for gene delivery.
Ghani K; Cottin S; de Campos-Lima PO; Caron MC; Caruso M
J Gene Med; 2009 Aug; 11(8):664-9. PubMed ID: 19507185
[TBL] [Abstract][Full Text] [Related]
18. Pressure-induced fusogenic conformation of vesicular stomatitis virus glycoprotein.
Gomes AM; Pinheiro AS; Bonafe CF; Silva JL
Biochemistry; 2003 May; 42(18):5540-6. PubMed ID: 12731897
[TBL] [Abstract][Full Text] [Related]
19. Effect of amniotic fluid on cationic lipid mediated transfection and retroviral infection.
Douar AM; Themis M; Sandig V; Friedmann T; Coutelle C
Gene Ther; 1996 Sep; 3(9):789-96. PubMed ID: 8875227
[TBL] [Abstract][Full Text] [Related]
20. Transduction efficiency of pantropic retroviral vectors is controlled by the envelope plasmid to vector plasmid ratio.
Chen Y; Miller WM; Aiyar A
Biotechnol Prog; 2005; 21(1):274-82. PubMed ID: 15903266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
